Washington University School of Medicine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Washington University School of Medicine sits in the top decile of US sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count).
Washington University School of Medicine: 1,502 sponsored US clinical trials, 214 recruiting.
Washington University School of Medicine sponsors 1,502 registered US clinical trials on ClinicalTrials.gov, 214 of them currently recruiting, and 919 completed. 98 of these trials are in Phase 3-4 (later-stage) and 569 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 20 trials.
Top-decile sponsor footprint
Washington University School of Medicine ranks in the top decile of sponsors by registered trial count (#12 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
919 of 1,159 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,502 total, page 2 of 31
Effect of Ketone Esters on Liver Fat Content and Metabolic Function
NCT07097506
Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICU
NCT07219108
Pain in Juvenile Arthritis
NCT07217782
Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients
NCT07166120
Characterizing the Human Airway Immune Response to FluMist Vaccination
NCT07177417
Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City
NCT07673380
This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.
NCT07115017
Adapting, Implementing and Evaluating the Effectiveness of HARP for People With Disabilities
NCT07033897
Propranolol for the Treatment of Kaposi Sarcoma in Adults
NCT06445166
Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With Obesity
NCT07091500
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
NCT07109427
Neuroimaging of Parkinson's
NCT07024875
Reducing Obstructive Sleep Apnea After Hypoglossal Nerve Stimulation Through Mandibular Advancement
NCT07132307
Fortifying Healthy Behaviors, Optimizing Medical Therapies and Enhancing Cognitive Function in Older Adults-pilot Study
NCT07000734
WashU DIEP Flap Video and Patient Understanding Improvement
NCT06864754
Advancing Biopsychosocial Care Training Initiative
NCT07049861
CONNECT Cancer Survivors With Tobacco Treatment
NCT07020273
Obstructive Sleep Apnea Non-PAP Outcomes and Viable Alternatives
NCT07074288
Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors
NCT05994209
ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction
NCT06981208
Just-In-Time Adaptive Interventions (JITAIs) in a Digital Mental Health Intervention for Middle-Aged and Older Adults With Chronic Pain
NCT06978166
MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma
NCT06648434
Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
NCT06976853
Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
NCT06898333
The Minimalist Trial-2
NCT06702033
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
NCT06904365
Auricular VNS Following Intracerebral Hemorrhage
NCT06799390
Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Reconstitution in Multiple Myeloma Patients After Autologous Hematopoietic Cell Transplant
NCT06523699
Window of Opportunity Study of DSP-0390 in Gliomas
NCT06636162
Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid
NCT06910670
Brain Organization, Development, and Response to Intervention in Individual Neonates
NCT05843396
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
NCT06529822
Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain
NCT06549985
Implement and Test Visual Consent Template and Process
NCT06804837
Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2
NCT06848309
Role of KATP Channel Loss in Type 2 Diabetes
NCT06830096
Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Stage II
NCT06867549
64Cu-LLP2A for Imaging Hematologic Malignancies
NCT06636175
Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility Trial
NCT06751355
Mechanism of Ketogenic Diet-Induced Hypercholesterolemia
NCT06894004
Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome
NCT06538181
Endometriosis and Migraine
NCT06785129
Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer
NCT06529809
Rejection Sensitivity and Puberty in Mental Health Vulnerability to Social Media Experiences in Early Adolescent Girls
NCT06777823
Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
NCT06374459
CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
NCT06687772
Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance
NCT06483100
Light Therapy for Obsessive-compulsive Disorder (OCD)
NCT06720090
Maternal Maneuvers During Prolonged Labor
NCT06636149
Mindfulness to Enhance Cognitive Health in Latinx Older Adults
NCT07040904
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 332 |
| Phase 2 | 237 |
| Phase 3 | 40 |
| Phase 4 | 58 |
Therapeutic Areas
What is open in the Washington University School of Medicine pipeline
214 recruiting of 1,502 indexed (14% open); 919 completed (61%).
Phase mix: 98 late (III/IV) vs 569 early (I/II) (early-phase heavy).
Top condition: Obesity (20 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Washington University School of Medicine: open-pipeline peers nationwide
Peers matched on 1,502 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Washington University School of Medicine sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,502 trials (± recruiting share)
- Yale University · 1,492 trials · 17% recruiting
- Johns Hopkins University · 1,448 trials · 17% recruiting
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Academic and Community Cancer Research United · 14% recruiting · 42 trials
- Adaptive Biotechnologies · 14% recruiting · 7 trials
- AgelessRx · 14% recruiting · 7 trials
- Alaska Blind Child Discovery · 14% recruiting · 7 trials
Related
What to do with this Washington University School of Medicine page
1,502 registered trials is a research-attention snapshot, not an endorsement of Washington University School of Medicine or any single study.
- 214 of Washington University School of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Washington University School of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Washington University School of Medicine pipeline card: 1,502 registered trials from official public datasets.Report a data error.